| scholarly article | Q13442814 |
| P356 | DOI | 10.1016/J.THROMRES.2006.12.019 |
| P698 | PubMed publication ID | 17434577 |
| P50 | author | Martin O'Donnell | Q37392962 |
| P2093 | author name string | Sara L Partington | |
| Koon Teo | |||
| Simona Abid | |||
| Wesley Oczkowski | |||
| P433 | issue | 5 | |
| P921 | main subject | anticoagulant | Q215118 |
| (RS)-warfarin | Q407431 | ||
| Atrial Fibrillation | Q815819 | ||
| anticoagulation | Q63279445 | ||
| P304 | page(s) | 663-669 | |
| P577 | publication date | 2007-04-16 | |
| P1433 | published in | Thrombosis Research | Q15758741 |
| P1476 | title | Pre-admission warfarin use in patients with acute ischemic stroke and atrial fibrillation: The appropriate use and barriers to oral anticoagulant therapy | |
| P478 | volume | 120 |
| Q35986742 | A case-based approach to implementing guidelines for stroke prevention in patients with atrial fibrillation: balancing the risks and benefits |
| Q36460629 | Adherence to Guidelines for Antithrombotic Therapy in Patients with Atrial Fibrillation According to CHADS2 Score before and after Stroke: A Multicenter Observational Study from Korea |
| Q35301441 | An automated clinical alert system for newly-diagnosed atrial fibrillation |
| Q47706652 | Anticoagulant Therapy in Atrial Fibrillation for Stroke Prevention: Assessment of Agreement Between Clinicians' Decision and CHA2DS2-VASc and HAS-BLED Scores |
| Q38043562 | Anticoagulation bridging around device surgery: compliance with guidelines |
| Q35161633 | Antithrombotic therapy in elderly patients with non-valvular atrial fibrillation: a pilot study. |
| Q37495770 | CHADS2 and CHA2DS2Vasc-Score in Peripheral Systemic Embolism |
| Q37033125 | Correlation between CHADS2 score and anticoagulant use in atrial fibrillation: Results of a mini-survey |
| Q45052852 | Delivery of optimized anticoagulant therapy: consensus statement from the Anticoagulation Forum |
| Q36256010 | Do NOACs Improve Antithrombotic Therapy in Secondary Stroke Prevention in Nonvalvular Atrial Fibrillation? |
| Q53459076 | Left atrial appendage closure with amplatzer cardiac plug in atrial fibrillation: Initial european experience |
| Q36723401 | Novel oral anticoagulants for stroke prevention in atrial fibrillation: a focus on the older patient |
| Q92741601 | Optimal Choice of Pharmacological Therapy - Prevention of Stroke and Assessment of Bleeding Risk in Patients with Atrial Fibrillation |
| Q35784686 | Paroxysmal atrial fibrillation and the hazards of under-treatment |
| Q33941300 | Percutaneous elimination of the left atrial appendage in quest for effective and safe prevention of stroke in patients with atrial fibrillation |
| Q35062723 | Performance of stroke risk scores in older people with atrial fibrillation not taking warfarin: comparative cohort study from BAFTA trial |
| Q37782417 | Reasons for non-use of proven pharmacotherapeutic interventions: systematic review and framework development. |
| Q37661487 | Reasons for undertreatment with oral anticoagulants in frail geriatric outpatients with atrial fibrillation: a prospective, descriptive study |
| Q37945342 | Stroke prevention in elderly patients with atrial fibrillation: challenges for anticoagulation. |
| Q37030961 | The use of anticoagulants in the management of atrial fibrillation among general practices in England |
| Q28553496 | Under-prescribing of Prevention Drugs and Primary Prevention of Stroke and Transient Ischaemic Attack in UK General Practice: A Retrospective Analysis |
| Q38776019 | Use of Oral Anticoagulant Therapy in Older Adults with Atrial Fibrillation After Acute Ischemic Stroke. |
| Q45113452 | Utilisation of antithrombotic therapy for stroke prevention in atrial fibrillation in a Sydney hospital: then and now. |
Search more.